share_log

康希諾生物(06185.HK)Tdcp疫苗II期臨床試驗完成首例受試者入組

AASTOCKS ·  Dec 22, 2024 20:19

康希諾生物(06185.HK)公布,公司開發的吸附無細胞百白破聯合疫苗(青少年及成人用Tdcp疫苗)於近日正式啟動II/III期臨床試驗,並完成II期臨床試驗首例受試者入組。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment